Neuroleptic malignant syndrome is rare, but this will be encountered in the ICU. Particularly with the rising utilization of antipsychotics for a variety of indications (e.g., emesis, agitation), we should be cognizant of this entity. Another relevent cause of NMS is abrupt withdrawal of Parkinson's medications (e.g., due to NPO status).
-
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
Latest posts by Josh Farkas (see all)
- Pulmcrit wee: The cutoff razor - April 15, 2024
- PulmCrit Blogitorial – Use of ECGs for management of (sub)massive PE - March 24, 2024
- PulmCrit Wee: Propofol induced eyelid opening apraxia – the struggle is real - March 20, 2024
excellent, as always Josh.
it seems that after 30 years I should get these straight. serotonin syndrome , malignant hyperthermia and NMS, but my skull is thick. this pod got through a bit.
thank you!
Just a useful addition: the NHS has an online calculator (http://www.parkinsonscalculator.com/) which provides conversions for both oral to NG and oral to transdermal for patients with Parkinson’s disease. It uses quintessential UK drug terminology, but is really useful – especially for patients on complex regimens.